Summary:

1. The global gene panel market size reached USD 1,153.2 Million in 2024.

2. The market is expected to reach USD 3,775.0 Million by 2033, exhibiting a growth rate (CAGR) of 14.08% during 2025-2033.

3. North America leads the market, accounting for the largest gene panel market share.

4. Test kits accounts for the majority of the market share in the products and services segment as they are easy to use and accurate.

5. Amplicon-based approach leads the market segment as it is highly cost-effective and efficient.

6. Predesigned gene panel dominates the market owing to its extensive use in diagnostics and research, and cost effectiveness.

7. Cancer risk assessment represents the leading application segment, owing to the prevalence of cancer.

8. Academic and research institutes account for the major market share, due to their predominant focus on research and innovation.

9. The rapid advancement in genetic testing is a primary driver of the gene panel market.

10. The gene panel market growth and forecast highlight a significant rise due to the growing awareness about personalized medicine and genetic testing.

Industry Trends and Drivers:

1. Technological Advancements in Genetic Testing

The growth of the gene panel market share can be largely attributed to the rapid technological advancements in genetic testing. With the increasing availability and affordability of high-throughput sequencing technologies like next-generation sequencing (NGS), the use of gene panels has become more accessible and accurate. Gene panels allow for the simultaneous analysis of multiple genes associated with various diseases, enabling clinicians to make more informed decisions. These advancements in sequencing technologies have reduced the cost of testing, making genetic testing more feasible for both clinical and research applications. Furthermore, improvements in bioinformatics tools and databases have streamlined the analysis and interpretation of complex genetic data, making gene panels more reliable and efficient.

1. Increasing Awareness and Market Trends in Personalized Medicine

The rise in awareness surrounding genetic testing and personalized medicine is significantly shaping gene panel market trends. As patients and healthcare providers increasingly recognize the benefits of personalized treatments, there has been a surge in demand for gene panels that can identify genetic mutations linked to various conditions. The growing understanding that genetic predispositions can influence disease risk, progression, and treatment outcomes has driven the adoption of gene panels in precision medicine. Moreover, the trend toward preventive healthcare is also supporting the demand for genetic screening and diagnostics, as gene panels can detect early genetic markers of diseases, potentially leading to early interventions. On the research front, gene panels are being employed to understand the genetic underpinnings of complex diseases and to develop targeted therapies, which aligns with the broader trend of individualized treatment regimens. The use of gene panels is also gaining traction in oncology, where genetic profiling of tumors is crucial for selecting the most effective treatment. The gene panel demand is hence expected to continue growing, driven by a shift toward more personalized, targeted healthcare strategies and advancements in genetic research.

1. Expansion of Healthcare Applications

The gene panel market size is witnessing significant expansion due to the broadening scope of healthcare applications. Gene panels are now being used across various sectors, including oncology, cardiology, infectious diseases, and prenatal screening. In oncology, for instance, gene panels are critical in identifying genetic mutations that can guide targeted therapies, improving patient outcomes and minimizing adverse effects. The cardiovascular sector is also increasingly utilizing genetic testing to assess genetic risk factors for heart diseases, facilitating early prevention strategies. Furthermore, gene panels are gaining popularity in prenatal screening to detect inherited genetic disorders in unborn children, further driving market adoption.

Request Sample For PDF Report: https://www.imarcgroup.com/gene-panel-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Products and Services Insights:

1. Test Kits

2. Testing Services

Test kits account for the majority of shares due to their ease of use, accuracy, growing adoption in clinical diagnostics, and the increasing focus on early detection of genetic disorders and personalized medicine.

Technique Insights:

1. Amplicon-based Approach

2. Hybridization-based Approach

Amplicon-based approach leads the market segment owing to its high efficiency, cost-effectiveness, and suitability for targeted sequencing.

Design Insights:

1. Predesigned Gene Panel

2. Customized Gene Panel

Predesigned gene panel represents the largest segment as these panels are cost effective and are extensively used in diagnostics and research, offering a ready-to-use solution for common genetic testing needs.

Application Insights:

1. Cancer Risk Assessment

2. Diagnosis of Congenital Diseases

3. Pharmacogenetics

4. Others

Cancer risk assessment exhibits a clear dominance owing to rising cancer prevalence and the need for early detection strategies.

End User Insights:

1. Academic and Research Institutes

2. Hospital and Diagnostic Laboratories

3. Pharmaceutical and Biotechnology Companies

Academic and research institutes account for the largest share due to their extensive focus on genetic research and innovation, and the significant funding from government agencies and private organizations that support large-scale genomic projects.

Market Breakup by Region:

1. North America (United States, Canada)

2. Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

3. Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

4. Latin America (Brazil, Mexico, Others)

5. Middle East and Africa

North America holds the leading position owing to the extensive utilization of next-generation sequencing technologies, its leading-edge healthcare infrastructure, and elevated investments in genomic research.

Top Gene Panel Market Leaders:

1. Agilent Technologies Inc.

2. BGI Genomics Co. Ltd. (BGI Group)

3. Eurofins Scientific SE

4. F. Hoffmann-La Roche AG

5. Genewiz LLC (Azenta Inc.)

6. Illumina Inc.

7. Integrated DNA Technologies Inc. (Danaher Corporation)

8. Novogene Co. Ltd.

9. Qiagen N.V.

10. Thermo Fisher Scientific Inc.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.